The involvement of astrocytes in propagating inflammation in ALS has been extensively described [31,61,62], and we have previously demonstrated that in vivo administration of MSCs reduced astrocyte pathological activation and IL-β and TNF-α expression in the spinal cord of SOD1G93A mice [39]. The gene discussed is TNF; the disease is amyotrophic lateral sclerosis.